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Abstract
Background: Chronic Fatigue Syndrome (CFS) is increasingly recognized as a cause of disability and inactivity in
adolescents in the Netherlands. CFS is characterized by unexplained fatigue lasting more than 6 months. Cognitive
Behavioural Therapy (CBT) has proven to be effective. However, CBT availability for adolescents with CFS is limited
and requires special therapeutic skills not always readily available. An alternative to the face-to-face CBT is FITNET,
a web-based therapeutic program designed specifically for adolescents diagnosed with CFS, and their parents. This
new CBT approach appeals to the modern youth, who grow up with internet as their main source of information.
A web-based program offers the opportunity to lower thresholds for the acceptance and realization of healthcare.
This treatment can be activated at any chosen time. The communication between patient and therapist can elapse
asynchronously. If effective, this web-based program would greatly increase the therapeutic accessibility.
Methods/Design: A randomized clinical trial is currently conducted. One-hundred-forty adolescents aged
12-18 years diagnosed with CFS will be recruited and randomized to one of two groups: FITNET or usual care.
After 6 months, the usual care group will have access to the FITNET program. Outcomes will be assessed at
baseline, post intervention, and at 6 months follow-up. Primary outcome measures are school presence, fatigue
severity, and physical functioning.
Discussion: The FITNET study is the first randomized clinical trial which evaluates the effect of web-based CBT
versus usual care in adolescents with CFS. The intervention is based on a theoretical existing model of CBT for
patients with CFS. The results of this study will provide information about the possibility and efficacy of web-based
CBT for adolescents with CFS and will reveal predictors of efficacy.
Trial registration: ISRCTN: ISRCTN59878666 and ClinicalTrials.gov: NCT00893438
Background
Chronic fatigue syndrome (CFS, also known as myalgic
encephalomyelitis/encephalopathy or ME) is a disabling
disorder, characterized by persistent or relapsing severe fati-
gue that is not the result of an organic disease or ongoing
exertion and is not alleviated by rest. Symptoms last for at
least 6 months and are accompanied by other symptoms
like muscle pain and concentration problems [1].
The cause of CFS is still unknown. CFS is explained in
terms of a central neurobiological disturbance with trig-
gering, sustaining and perpetuating factors both on a
biological and psychosocial level [2]. Cognitions con-
cerning these sustaining and perpetuating factors are
subject of the cognitive behavioural therapy (CBT) regi-
men for adolescents. CBT is the only evidence-based
treatment with a recovery rate of 70% directly after
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treatment [3]. An uncontrolled study of the efficacy of
family cognitive behaviour therapy for adolescents with
CFS, revealed even better results with a recovery rate of
83%, with a maintained gain at 6 months follow-up [4].
However, the availability of this treatment in the Neth-
erlands is limited and it requires special therapeutic
skills that are not always readily available.
Furthermore, not all cases of CFS are adequately
recognised, neither by the patient nor by their doctor.
A large population study in the Netherlands revealed a
prevalence rate of 16.4% of severe fatigue lasting more
than one month in adolescent girls [5]. The proportion
of undiagnosed cases of CFS among these girls is
unclear. The lack of treatment possibilities within reach
may enhance the reticence in diagnosing CFS.
Although untreated CFS in adolescents has a better
prognosis than in adults, the risk of disruption of devel-
opment and education asks for a prompt recognition of
the syndrome and an effective treatment method [3,6].
The longest follow-up study, covering a 13 year follow-
up period, showed that the majority of adolescents have
mild to moderate persisting symptoms with a consider-
able period of school absence [6].
The lack of skilled cognitive behavioural therapists to
treat adolescents with CFS made us decide to develop a
web-based application combing CBT by a skilled thera-
pist with a regular internet contact. In a recently pub-
lished non-inferiority randomised controlled trial (RCT)
by the Expert Centre for Chronic Fatigue (ECCF) in Nij-
megen, a minimal intervention based on CBT for CFS,
consisting of a self help booklet (workbook) supported
by email contact with a cognitive behavioural therapist,
appeared to be effective [7]. This Self Help Program
resembles a web-based CBT in certain aspects, such as
the absence of face-to-face contact between therapist
and patient. However, in the minimal intervention study
the contact between therapist and patient was minimal,
whereas in the web-based CBT there will be frequent
email contact between therapist and patient.
Web-based CBT for illnesses other than CFS has been
found effective, but most research has been conducted
with adults [8,9]. For adolescents, web-based CBT has
been developed for disorders such as obesity [10],
depression [11], anxiety [12], headache [13] and smok-
ing cessation [14]. The efficacy of these web-based CBT
programs in general is comparable with the face-to-face
treatments [8,9,13,15].
FITNET (web-based treatment for Fatigue In Teen-
agers) is a Dutch web-based program developed in close
collaboration between the Wilhelmina Children’s Hospi-
tal (University Medical Centre Utrecht, UMCU) and the
Expert Centre for Chronic Fatigue (Radboud University
Nijmegen Medical Centre, ECCF). FITNET is a highly
structured program for adolescents with CFS and
consists of two parts: a psycho-educational part for both
adolescents and parents and a CBT part based on the
protocol of the ECCF [16]. The efficacy of this protocol
in a face-to-face setting for adolescents has been
demonstrated in a randomized controlled trial [3].
The primary aim of this study is to determine the effi-
cacy of FITNET for adolescents with CFS in the Nether-




A single-blinded randomized clinical trial (RCT) with 6
months follow-up will be conducted to evaluate the effi-
cacy of FITNET compared to usual care for adolescents
with CFS. Efficacy of FITNET compared to usual care
will be determined after 6 months, the maximum dura-
tion of the treatment. Patients assigned to FITNET have
to agree to not have any further medical examinations
or other treatments for fatigue whilst in therapy [17].
The adolescents who have been assigned to the usual
care will get the opportunity to attend the program after
these 6 months. The total follow-up time is 12 months
after the start of the web-based program. (see Figure 1).
CFS will be diagnosed after a uniform diagnostic
work-up by a paediatrician specialised in CFS (EP),
according to CDC-criteria [1]. Once the diagnosis is
established, study eligibility will be assessed by complet-
ing self-reported questionnaires on fatigue, physical
complaints, physical functioning, depression and anxiety.
Eligible patients will be asked to participate in this RCT.
If the patient is willing to participate, the primary inves-
tigator (SN) will check the inclusion and exclusion cri-
teria (table 1). When a patient meets all criteria, oral
and written consent will be obtained from both patient
and at least one parent, according to the declaration of
Helsinki. The patients with a possible psychiatric
comorbidity and their parents will be examined by an
experienced child psychologist before randomisation.
Patients with a primary psychiatric diagnosis, as assessed
by this psychologist, will be excluded from the trial. If
the adolescent or the parent(s) decide not to participate
in the study, the reason will be asked and specified,
although they are not obligated to reveal such reasons.
During the intervention we expect some adolescents to
drop-out. The reason to stop will be asked and specified.
Study population
It is intended to include 140 adolescents aged 12-18
years old, referred to the University Medical Centre
Utrecht (UMCU) and diagnosed with CFS using the
CDC-criteria [1].
The patients will be recruited from second-line medical
care by means of the National Surveillance Centre for
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Children (NSCK), which is part of the International Net-
work of Pediatric Surveillance Units, INoPSU [18]. The
NSCK survey guarantees a high percentage of reporting
(83-92%) of the diagnosis under consideration. Recruit-
ment from primary care will be realised by announce-
ment of this study to all General Practitioners in the
Netherlands (with help of the NIVEL, the Dutch Colla-
borating Centre of the WHO). In addition, on the web-
site of the ‘CVS-ME Stichting’ (a Dutch CFS Foundation)
a direct call to participate in this study will be published.
Ethical approval
This study has been reviewed and approved by the Medical
Ethical Committee of the University Medical Centre
Utrecht (reference 07/196-K) and the Medical Ethical Com-
mittee of the Radboud University Nijmegen Medical Centre
(reference AMO nr. 07/105). Patients and their parents
receive verbal and written information about the study and
informed consent will be obtained before randomisation.
Randomization and blinding
Concealed randomisation will be performed by the data-
management section of the Julius Centre for Health
Table 1 Inclusion and exclusion criteria
Inclusion criteria
(1) The participant has given written informed consent
(2) CFS diagnosis according to the CDC criteria [1]
(3) Adolescent between 12-18 years old at inclusion
(4) Fatigue severity subscale (CIS-20) score ≥40 (healthy
population’s mean plus two SD) [19]
(5) Physical functioning (Child Health Questionnaire) score <85
(healthy population’s mean minus two SD) and/or school
participation ≤85% (healthy population’s mean minus two SD) in
last two weeks [20]
Exclusion criteria
(1) Inadequate control of Dutch language by child or parent
(2) No availability of computer hardware and internet connection
(3) Suicide risk as assessed on the Children’s Depression Inventory
(CDI) [21]
(4) Cognitive retardation (when indicated an IQ-test will be
conducted; IQ <85 will be excluded)
(5) Score greater than or equal to 44 (healthy population’s mean
plus two SD) on the State-Trait Anxiety Inventory for Children
(STAIC) [23]
(6) Score greater than or equal to 16 (healthy population’s mean
minus two SD) on the Children’s Depression Inventory (CDI) [21]
Figure 1 Flowchart of trial design.
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Sciences and Primary Care Utrecht. This randomization
is computer-generated by creating ‘blocks’ with a size of
6, ensuring that the same number of participants will be
allocated to each group. The investigators who are
responsible for the inclusion will be blinded. Primary
outcome parameters will be assessed by computer.
Interventions
Usual care
The patients in the control group will receive the usual
care available in the region where the patient lives. The
available usual care for adolescents with CFS in the
Netherlands includes: individual/group based rehabilita-
tion programs, psychological support including CBT
face-to-face, graded exercise therapy by a physiothera-
pist, etc. All care received will be monitored during the
study.
Web-based Cognitive Behavioural Therapy (FITNET)
FITNET is a web-based cognitive-behavioural treatment
accessible to patients and both parents, based on the
existing face-to-face CBT protocol for adolescents devel-
oped by the ECCF [3,17]. Trained cognitive behavioural
psychotherapists from the ECCF will support the
patients by e-consults. There will be no face-to-face
contact between the therapists and patients at all.
The web portal is designed by the UMCU in colla-
boration with the ECCF, and has been developed in
cooperation with adolescents with CFS who critically
appraised text, lay-out and structure. Two authors of
children books (Mr. and Mrs. van Hagen) revised the
textual content on readability for adolescents. All thera-
pists receive a special half a day training in the applica-
tion of written language for this target group.
The programme consists of a psycho-educational and
a CBT section. The psycho-educational section will be
readily available, after receiving log in codes. The CBT
section consists of 21 interactive modules (see appendix
1), accessible upon activation by the therapist. The web-
based therapy comprises about 20 internet-sessions over
6 months. Meanwhile, the parents will follow a parallel
program. All users will have a unique username and
password, ensuring private communication with the
therapist. Both parents and adolescents will have a regu-
lar e-consult (email contact) with the therapist, wherein
results so far are discussed and new assignments can be
given. The therapist will reply on a fixed weekday. The
patient will have the ability to send an emergency email,
on which a prompt reply will be made. For emergency
situations, telephone contact details are available for the
patient.
The FITNET treatment programme is implemented in
a portal with a lay-out especially designed for adoles-
cents, combining different applications such as: e-consult,
personal diaries, questionnaires, psycho-education, all
treatment steps and the possibility to review previous
communications and assignments. Patient data and
emails will be encrypted and securely stored on the
UMCU mainframes to guarantee privacy and confidenti-
ality. The treatment protocol is described in more detail
in the appendix.
Compliance and attrition
Therapy compliance will be assessed by recording the
number of treatment-modules (CBT) that have been
completed. When applicable, participants will be asked
for their reasons for poor compliance. In the case of
therapy drop-out, patients will be asked for the reason
of non compliance and stimulated to continue participa-
tion in the assessments until the last follow-up.
Outcomes
Outcome measures and predictors of outcome are listed
in table 2.
The primary outcome measures are: (1) Fatigue as
measured by the subscale fatigue severity (8 items,
7-points Likert Scale) of the Checklist Individual
Strength-20 [19] with a severity range from 8-56. The
questionnaire has good reliability and discriminative
validity. (2) Physical functioning as measured by the
subscale physical functioning (9 items) of the validated
Dutch translation of the Child Health Questionnaire
(CHQ-CF87) (0-100%) [20], and (3) School presence
(expressed in attended hours/obliged hours * 100%) as
assessed in prior intervention studies in adolescents
with CFS [3]. Secondary outcome measure is self-rated
improvement, measured using a short questionnaire
consisting of 4 items as assessed in prior intervention
studies in adolescents with CFS [3]: patients indicate
whether they have completely recovered, feel much bet-
ter, have the same complaints of have become worse
compared with the previous measurement.
Outcome measures will be obtained at the UMCU at
the start of the study period (T0), after the intervention
6 months later (T1) and after 6 months follow-up (T2).
For those adolescents primarily allocated to usual care
who will start with FITNET at T1 - in case of no recov-
ery - there will be an extra follow-up moment after 12
months (T3), see figure 1.
At the first measurements (T0) demographic data and
the following predictors of response to treatment and
measures of processes of change will be obtained by the
primary investigator (SN) both for adolescent and par-
ent(s) (see table 2). Possible predictors of response to
treatment in adolescents are: (a) Depression score (vali-
dated Dutch translation of the Child Depression Inven-
tory, CDI) [21,22], (b) Anxiety (Dutch translation of the
Spielberger State-Trait Anxiety Inventory for Children,
STAIC) [23,24], (c) Number and severity of other
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somatic symptoms measured by a validated Dutch trans-
lation of the Children’s Somatisation Inventory (CSI)
[25,26], (d) Physical performance as measured with the
actometer. This is a motion-sensing device worn at the
ankle that registers and quantifies physical activity. The
actometer is worn day and night during a period of
twelve consecutive days [27]. During the same days
patients rate fatigue, pain and activity levels on a pre-
scheduled diary four times daily on a scale of 0 (not at
all) to 4 (very much). Daily registration of hours being
at school is registered as well. The psychometric quali-
ties are good [28], (e) Self-efficacy (Self Efficacy Scale-
28) [2], (f) Perceptions of parental rearing behaviours
(the adolescent version of the Egna Minnen Beträffende
Uppfostran, EMBU-A) [29].
Possible parental predictors of response to treatment
are: (a) Parental fatigue (Checklist Individual Strength-
20) [19], (b) Parental psychological distress measured by
the Symptom Checklist (SCL-90) [30,31], (c) Parental
focussing on bodily symptoms by the subscale private
body consciousness of the Body Consciousness Scale
[32,33], (d) EMBU-P, the parental version of the Egna
Minnen Beträffende Uppfostran [34], (e) parental causal
attributions to the origin of CFS (Causal Attribution
List, CAL) [19,28].
Finally, the patients and parent(s) treated with FITNET
(including the drop-outs) will be interviewed (responsive
evaluation) about their experiences with the FITNET
intervention. The interviews are semi-structured, with
open questions guided by a topic list (10 point scale,
questionnaire especially developed for this study). Differ-
ent aspects of this web-based programme will be evalu-
ated: text, lay-out, feedback by the therapist, scheduling
of modules, technical experience, etc.
Adverse events
The delivery of CBT to adolescents and adults is consid-
ered safe.
All adverse events reported spontaneously by the par-
ticipants or observed by the therapists will be recorded.
All adverse events will be followed until they have
aborted, or until a stable situation has been reached.
Statistical Analysis
One-hundred-forty newly diagnosed CFS patients will be
included in two years. The data will be analysed on an
intention to treat basis. Prognostically important base-
line characteristics will be tabulated by treatment mod-
ality in order to evaluate success of randomisation. The
main efficacy analysis will pertain to the data obtained
after a 6 months FITNET or usual care condition. Dif-
ferences between treatment groups concerning the pri-
mary outcome measures will be expressed as relative
risks and 95% confidence intervals or as central estima-
tors and variance measures where appropriate. In case
of baseline differences in prognosis between groups,
treatment effects in primary outcome will additionally
be adjusted for these differences using logistic regression
Table 2 Outcome measures, predictors of outcome and instrumentation
Instruments T0 T1 T2 T3
Primary outcome parameters
Fatigue severity Checklist Individual Strength (CIS subscale fatigue) [19] X X X X
Physical Functioning Child Health Questionnaire (CHQ-CF87 subscale physical functioning) [20] X X X X
School presence Last two weeks school presence expressed in attended hours/obliged hours * 100%[3] X X X X
Secondary outcome parameters
Self rated improvement short questionnaire consisting of 3 items [3] X X X X
Possible patient’s predictors of treatment outcome
Depression score Child Depression Inventory (CDI) [21,22] X
Anxiety score Spielberger State-Trait Anxiety Inventory for Children, STAIC [23,24] X
Somatisation score Children’s Somatisation Inventory (CSI) [25,26] X
Physical activity Actometer and Self-observation list daily functioning [27,28] X X X
Self-efficacy Self Efficacy Scale-28[2] X
Perceptions of parental rearing behaviours EMBU-A [29] X
Possible parental predictors of treatment outcome
Fatigue severity Checklist Individual Strength (CIS subscale fatigue) [19] X
Psychological distress Symptom Checklist (SCL-90) [30,31] X
Focussing on bodily symptoms subscale private body consciousness of the Body Consciousness Scale [32,33] X
Perceptions of rearing behaviours EMBU-P [34] X
Causal attributions CAL [19] X
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for binary outcome data and linear regression for con-
tinuous outcome measures. At 12 months follow-up
after randomization, a repeated measurement of the pri-
mary outcome measures will be undertaken as well as
an evaluation of participants’ experiences with the FIT-
NET intervention. The latter measurements will have a
descriptive nature.
Concerning the predictors of outcome, the study will
be merely exploratory because statistical power is not
calculated for subgroup analyses. To that end, linear
regression analysis will be used with primary continuous
outcome measures as dependent variables and interac-
tion terms of putative response predictors and treatment
modality as independent variables. Separate analyses will
be run for predictors in adolescents and predictors in
parents respectively.
Power
We estimate that under care as usual the estimated
average percentages of school absence, our primary end-
point, at the end of follow-up, will be 40%. Given the
efficacy of face to face CBT in adolescence [3] we con-
sider a reduction of school absence of 15% in the e-
intervention group to be realistic and highly relevant. In
order to statistically detect such a reduction, given a 2
sided-alpha of 0.05 and with 90% power, we will need to
allocate 60 patients to each group. In order to accom-
modate a small anticipated percentage of non-participa-
tion we will include 140 diagnosed patients.
Discussion
To the best of our knowledge, the FITNET study will be
the first randomized clinical trial which evaluates the
effect of web-based treatment versus usual care in ado-
lescents with CFS.
This study has several strengths. Firstly, the FITNET
treatment is based on a theoretical model of a proven
effective face-to-face CBT for adolescents [3] and will be
compared with usual care in a randomized design. This
will enable to determine the additional value of FITNET
in the current therapeutical spectrum. Secondly, FIT-
NET involves parents in the treatment of adolescent
CFS. Earlier studies from Chalder et al showed the
importance of family-focused CBT to achieve treatment
success in adolescents [4,35]. Furthermore, the advan-
tage of making treatment available at any time by
internet is considerable. Online treatment can reduce
face-to-face treatment barriers (i.e., inconvenience of
scheduling appointments, missing school/work, travel-
ling to and from a clinician’s office) [36,37], increase
adherence [38] and reduce treatment time and costs
[37]. We hope that a web-based treatment will increase
the therapeutic accessibility. A limitation of the study is
that the design is not appropriate to compare the
efficacy of web-based CBT with face-to-face CBT. That
would have asked for a non-inferiority design with com-
parison of the two interventions.
In conclusion, the FITNET study will provide greater
insight on evidence-based treatment options for adoles-
cents with CFS. If web-base CBT is more effective than
usual care, this web-based program would greatly
improve the prognosis of the adolescents with CBT.
Appendix 1: Overview of FITNET web-based CBT
treatment for adolescents with CFS
Psycho-educational part
What is CFS?
CFS in the Netherlands
CFS in my family
Causes of CFS
CFS, anxiety, depression and other illnesses
How is the diagnosis confirmed?
What is the treatment for CFS?
Talking about CFS/How do I explain what CFS is?
Future forecast
Cognitive Behavioural Treatment Modules
1. To introduce myself
2. How does this treatment work?
3. Assessing my present possibilities
4. My parents
5. My goals
6. My sleep routine
7. My thoughts
8. Changing my attention to fatigue
9. Step up my physical activities (passive patients)
10. Balance between activity and rest (relative active
patients)
11. Step up my physical activities (relative active
patients)
12. Recognizable problems with the treatment
13. Step up my mental activities
14. My schedule for school
15. My social activities
16. To reach goals
17. My schedule for work
18. To have a night out
19. Do I still see myself as a patient with CFS?
20. My evaluation
21. Follow-up
FITNET is derived from the protocol for CBT that
was developed on the basis of a model of perpetuating
factors of CFS [2]. It has been tested in several studies
[3,17,39] and is aimed at changing fatigue related cogni-
tions and a gradual increase of activities.
Typically, treatment involves (a) formulation of treat-
ment goals, (b) establishing a sleep routine, (c) encouraging
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the participant to achieve a balance between activity and
rest, (d) gradually increasing activities including home,
social and school life, (e) addressing cognitions about fati-
gue, (f) gaining independence from surroundings and par-
ents, (g) reducing the focus on fatigue, and (h) paying
attention to relapse prevention.
Addressing physical activity patterns is important in
CBT for adolescent CFS. The CBT modules are adapted
for two levels of physical activity: relative active and pas-
sive, based on the existing protocols [3,16,17]. An act-
ometer, a motion sensing device that can quantify
physical activity, will be used to assess the activity pat-
tern [27,32]. Adolescents with a relatively high physical
activity pattern alternate between periods of activity and
periods of rest [16]. For these patients the therapy
focuses on learning to recognise and accept their cur-
rent state of fatigue and impairment. Then they learn to
distribute their activities more evenly. After this, the
patient will start to build up activity levels. In contrast,
patients with a low physical activity pattern spend most
time lying down and go out infrequently. Most do not
attend school at all. For them, the treatment program
starts with a systematic build up of activity as soon as
possible, while addressing and challenging their beliefs
that activity would aggravate symptoms.
Modules 1, 2 and 4 introduce CBT and explain the role
of the therapists, and the context of the family.
A rationale based on a multi-factorial model of CFS that
distinguished predisposing, precipitating and maintaining
factors is presented. Parents will be actively involved in
supporting their child and parents’ beliefs and behaviours
regarding the condition of their child will be explored
and addressed. The aims of therapy take into account the
specific developmental tasks of adolescents. In children
younger than 15 years, parents often act as a coach; for
older participants, parents have to step back and encou-
rage their child to take responsibility for the treatment.
Modules 3 and 5 are focused on treatment goals.
Return to full time education is always a goal of treat-
ment, and a plan for returning to school will be dis-
cussed early with everyone involved.
Modules 6 to 19 focus on cognitive behavioural strategies
and include instructions and exercises on how to identify,
challenge and change cognitive processes that contribute
to CFS. There are two treatment protocols, depending on
the pattern of physical activity of the patient [16].
Module 20 evaluates treatment success.
Module 21 is a relapse preventing module focusing on
maintaining gains and staying healthy.
Diaries
Sleep diary, Helpful Thoughts, My goals, Activity sche-
dule, School schedule.
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